Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I've posted a link to the letter from the CEO in the Recent News section of the IBox.
ty3 - you are more than welcome to state your views, but stop spamming the board with the same phrase. You've stated your opinion, so now give others a chance to respond. And you may respond in turn, etc. There is no issue with you taking a negative view of the company and expressing your opinion so long as you do not attack others and refrain from writing the same phrase over and over again. If you are looking for facts/answers and the members of this board are unable to provide you with those, then you should take up your concerns with the company or look for answers somewhere else.
The rest of the board - keep it on topic and remember no personal attacks.
Thanks.
Looks like the CEO is learning a hard lesson. By the time the R/S goes thru, the split will just take the price back to where it was a couple months ago. Should have just had the shareholder meeting and you would have seen the price likely spike again.
Please make sure someone asks about financing going forward.
Shareholders have faced massive dilution and will now face a reverse split that history has shown will likely devalue our investment further, so how does the company intend to finance operations going forward? Is the company looking at financing that would increase shareholder value, such as a partnership with a major player, rather than financing thru a company such as Golden Gate (or other private investor) that will likely hurt individual shareholders?
if you're going to be arrogant and belittle others, at least be correct and make a valid point.
i'm not going to take the time to check all of the companies you listed, but i know the splits done by apple and microsoft were NOT reverse splits -- they were FORWARD splits with most being 2-1. in other words, if you had 100 shares, you ended up with 200 shares at half the price. this is the opposite of what tdcp is doing. FORWARD splits are actually viewed favorably.
i don't want to definitively say that all of the companies you listed did not do a reverse split at some point, but i HIGHLY doubt it. my guess is you simply looked up how many splits each company did and did not analyze whether they were forward or reverse.
so i'll let you apologize to the other investor...
up almost 16% today. hopefully it holds and we keep climbing into the meeting.
slightly confused by your post b/c after reading the 1st paragraph, i thought you were going to discuss how they have failed to meet most of their own timeline LoL!
i certainly agree they have made progress and have come a long way, but meeting their own timeline/expectation...not really. and definitely not ours.
looking forward to what comes out at the meeting. was going to go, but decided not to in the end. if someone takes photos/videos or does a write-up, let me know and i'll put it in the iBox.
as long as the therapy is selling and the acne treatment is approved, i think most of us will see a return in early-mid 2012. it won't be huge, but i would think we would at least get back up to where we were at FDA approval.
(but why do you need help with tuition? are you not rich enough to afford it? herman cain says it's your own fault.)
yeah, i can't believe someone didn't ask about the financing either. the guy from rodman used up most of the time.
yes, i believe $2-3k is the net. it sounded like the price may escalate post july 2012 -- did anyone else catch that or did i hear wrong?
i thought the Natural Air skin cream sounded promising. no product like it on the market as it uses own patients collagen and not bovine. would only be sold thru doctors, so you can bet the doctors will be pushing it as they won't have to compete with large retailers on their mark-up.
some quick numbers he threw out were:
4.2M injectable procedures in 2010 and growing despite recession
if FCSC captured 1.8% of market share (=75,600), that would equate to $150-$225M rev/yr. seems more than reasonable to me, but pernock did not expect to capture that share immediately.
3M acne scar patients/yr, which would equate to $5B rev/yr. currently no procedure for these people other than lasers, so could be a huge market. i believe he said they are expecting to hear from the FDA in a couple months.
25K burn scar patients/yr, which would equate to $100-$150M rev/yr. the 25k is new patients and not patients from past years
how exciting!
volume up a little today and at least the pps is going up. looks like some anticipation. would be nice to crawl above the 50ma and close above it. haven't seen that in months...
Surprised to see more people haven't been commenting. I read the PR and actually got a little excited, and I am looking forward to the call today. The product is now available, which means we are closer to seeing whether there is a strong demand for it, which most of us think there is.
good article. the huge trend in shorting biotech companies just piles the punishment onto investors as well.
I just voted "no". Not that it will matter what any of us vote because the company has enough votes to tow the line despite what it's "valued" shareholders think.
a stock buy back and retire the shares in lieu of a r/s would be a dream come true. but the odds of it happening are 0% -- not even 1%. we're not talking about berkshire here.
my take on recent events...
the short is i'm not selling and not buying. the chart was starting to shape up for a run and i had been contemplating loading up, especially since i thought the news about the shareholder meeting would be a small catalyst. glad i didn't. obviously the inclusion of the r/s killed those chances.
i was surprised to see that the reincorporation is going to be in nevada. i'd be curious to know why, as most businesses choose to incorporate in delaware. nevada has a shady history of shells due to some of their laws (i.e. strong laws protecting directors, etc.). i intend to ask the company why they chose nevada over delaware, and if anyone else can get an answer faster than i can, please let me know.
given the reincorporation, i'm not surprised to see the r/s. given they'll be reincorporating thru a merger, this will allow them to change the structure, so the timing makes sense.
bottom line is the company needs to show some sort of progress at the shareholders meeting. and as others have said, it would be hard to believe that they would invite shareholders for a meeting if they did not have some good news to share and just wanted to share the bad news about the r/s. if they do not have anything worthwhile to share, i would conclude management does not understand the current sentiment of its longtime shareholders. frankly, i think many of us are beyond wanting to only see technological advances and need to see that they are on a solid path towards generating revenue and actually creating value for shareholders. while the technology is promising, i am tired of seeing my investment diluted.
Need some buyers above .021 again
Nice volume today and up 5%. Maybe she runs...
currently sitting at the HOD just under .70. Would sure be nice to get past the 50MA...
I think the issue is there's just not much for him to say at this point.
Given the fact that the company did not say anything post FDA approval and investors were getting upset by the lack of communication, the company probably felt it had to communicate something to satisfy investors.
But, as I started off with, there's just not much to say. It was good to hear that everything is on track for launch in September. Manufacturing is good to go (with a blueprint for expansion). 125 physicians are on the waiting list to be trained, which is in the range of where they want to be. The various agencies (PR, advertising, training and physician recruiting) are all good to go. The other research and opportunities they are pursuing are coming along.
So, while he didn't seem to share anything new, at least he confirmed all is on track with the September launch. And they'll apparently be providing more regular updates from hear forward.
So, I guess the call didn't have groundbreaking news that will catapult the stock, but it was nice to hear all seems on track. For me, that was sufficient.
hopefully the call will be enough to get us pass the 50MA and 200MA again
umm...that is the point of having IR...so they can't answer questions
Basketball brawl between Georgetown Hoyas and Chinese last night...You guys see it? http://goo.gl/dDbn3
How about that for Sino-US relations?
Nice letter from the CEO. Also nice to be back above .02. Hopefully it holds in this range.
behind the scenes of the NYMEX gold market from cnn: http://goo.gl/zlsIO
cool behind the scenes coverage on gold market on NYMEX by CNN: http://goo.gl/zlsIO
cnn covers gold on NYMEX: http://goo.gl/zlsIO
cool behind the scenes coverage by cnn on gold at the NYMEX: http://goo.gl/zlsIO
Rick, I think we all pretty much feel the same way.
Not sure if you all saw this video already, but his reaction was very reminiscent of my reaction when FCSC released the news about the patent: http://goo.gl/onbR7
etrade baby loses everything
not sure whether you all saw this or not, but it's pretty funny...
http://videoforward.com/video.php?video=55028
The only time anyone sells any part of their company for financing is because they need the cash. And, FCSC desperately needed cash to bring the product to market.
It would have been nice if they could have negotiated a better deal to not give away so much, but I assume they had a figure in mind for how much cash they needed to bring the product to market and keeps things moving forward and that was the equity stake they had to give up to get it.
If I am not mistaken, $22M was significantly more than the funding they were able to raise previously, although I am not sure what stake they were giving up on previous deals.
At this point, all we can do is hope they use the money wisely and demand for the product proves strong.
The trading situation is not very fluid with the spread in the bid/ask recently. Right now, it is a 1 cent spread which is reasonable. But, I have noticed over the last few days the spread can range up to 5 cents which makes it very difficult to trade and make money. The only reasonable strategy I see would be to wait for it to hit near .45 or below and then wait a few more days for it to hopefully bounce up to mid .50s again.
Yep, agreed. The larger bargaining chip would be to demonstrate the demand for the product. Not, "Hey, we got $22M in financing by diluting our stock by X%"
I cannot rule out an acquisition/partnership. But given that we know the company needed money for production, marketing, expansion of production facilities, etc., this seems to be the most logical conclusion as to why the financing was done. It seems far-fetched that the company would close $22M in financing simply to use as a bargaining chip.
would be nice to hear something from the new CEO...
The completion of $22M in financing is very telling that all odds are against the company being acquired for the time being. Why move forward with the financing otherwise?
We know they need money to ramp up production and marketing efforts, so given they received money, this would be the most logical conclusion as to what is happening behind the scenes. And in that case, I would hope the company updates shareholders often on the progress.
Apart from being acquired, as I said a couple weeks ago, the only way the price moves up significantly is thru guidance that demonstrates a large demand for laviv and therefore potentially large profits. Unfortunately, I doubt we hear anything on this until late this year at best. Nevertheless, a PR stating that production is online and things are developing as expected (or better than expected) would be nice. Until then, we likely trade in a range with some dips and some spikes depending upon traders moving in and out.
Without news from the company, it will continue trading in a range between .50-.60 short term. Chart doesn't look thrilling at the moment so it won't attract any traders. Hopefully the company starts releasing news.
Given the media coverage the product received after FDA approval, I do not believe you can call it a "loser" product at this point. You may be correct that, ultimately, the price point will prove too high for consumers, but at this point, the only proof of demand is the media coverage the product received, which was high.
Unfortunately, at this point, I do not foresee any near-term (within the next month or so) news that will have significant affect on the PPS. Right now, the investment community wants to see some sort of guidance or indication of demand, which is what should make or break the stock in the medium-term. In the investment presentation the company posted, I believe it discussed 5,000 patients in the first 18 months. The hope would be that demand and their production capacity surges and they are able to beat the numbers already laid out. But, for now, we are in a waiting period as production rolls out.
So, not much to see here for the time being.
agreed. i am pretty much waiting to hear updates on both of these meetings.
yep, i keep putting in buy orders at 10 cent increments each time it breaks support. if it falls to .40, i plan to back the truck up.
To say the company is getting "hammered" is an over-exaggeration. You are trying to imply people are running for the exit, and given that volume has been very light and it's trading in the the same range it was in March/April, that's simply not true. Today, it broke the 200 day moving average, which isn't beneficial from a technical stand point and we're seeing that reflected in the PPS. We could see another dip, but if you're holding until the company starts generating revenue or is bought out, the paper loss isn't a big deal.
Plus, the current trading has no bearing on determining whether the company will be bought out so to suggest a correlation between the two is ridiculous. Should a company wish to acquire Fibrocell, their acquisition price will be based on potential earnings or perceived value (at this point given it does not currently have earnings) and not a multiple of the current stock price.